IMS Health

See the following -

2014 Health IT Venture Funds Fly High

Bernie Monegain | Healthcare IT News | January 19, 2015

Six companies attracted millions from top venture investors...

Read More »

HIT Venture Capital Hits $1B For First Time

Mike Miliard | Government Health IT | July 17, 2014

Venture capital funding for health information technology surpassed $1 billion for the first time in Q2 2014 – far surpassed, in fact, with $1.8 billion raised in 161 deals, more than doubling the $861 million raised in the previous quarter...

Read More »

How Data Brokers Make Money Off Your Medical Records

Adam Tanner | Scientific American | February 1, 2016

A growing number of companies specialize in gathering longitudinal information from hundreds of millions of hospitals' and doctors' records, as well as from prescription and insurance claims and laboratory tests. Pooling all these data turns them into a valuable commodity. Other businesses are willing to pay for the insights that they can glean from such collections to guide their investments in the pharmaceutical industry, for example, or more precisely tailor an advertising campaign promoting a new drug...

Read More »

mHealth, Data Analytics See $4.7 Billion In 2014 VC Funding

Jennifer Bresnick | EHR Intelligence | January 16, 2015

The past year saw a $4.7 billion investment in healthcare IT companies, according to a report from Mercom Capital Group, as venture capital firms seek to promote lucrative technologies in the practice-facing and consumer-facing markets.  Data analytics, population health management, and clinical decision support products were among the most likely to grab investor attention in 2014, while mHealth, telehealth, and wearable technologies saw $2.3 billion in major deals...

Read More »

Population Health, Analytics, mHealth Vendors Raise $1.8B In Q2

Jennifer Bresnick | EHR Intelligence | July 22, 2014

Health IT vendors have been raking in the dough at record levels, Mercom Capital says in a new report, charting the booming industry’s first $1 billion quarter in venture capital (VC) funding and smashing totals from the entirety of 2013...

Read More »

Soaring Generic Drug Prices Draw Senate Scrutiny

Matthew Perrone | ABC News | November 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington lawmakers...

Read More »

Strengthening Protection of Patient Medical Data

Adam Tanner | The Century Foundation | January 10, 2017

Americans seeking medical care expect a certain level of privacy. Indeed, the need for patient privacy is a principle dating back to antiquity, and is codified in U.S. law, most notably the Privacy Rule of the 1996 Health Insurance Portability and Accountability Act (HIPAA), which establishes standards that work toward protecting patient health information. But the world of information is rapidly changing, and in this environment, U.S. rules fall precariously short in protecting our medical data...

Read More »

This Little-Known Firm Is Getting Rich Off Your Medical Data

Adam Tanner | Fortune | February 9, 2016

You may never have heard of it, but IMS Health knows an awful lot about your medical history. A global company based in Danbury, Connecticut, IMS IMS 1.58% buys bulk data from pharmacy chains such as CVS CVS 0.72% , doctor’s electronic record systems such as Allscripts, claims from insurers such as Blue Cross Blue Shield and from others who handle your health information...

Read More »

TPP Treaty Could be a Serious Threat to US Public Health System

While trade agreements may seem to be another, albeit international species of wonkery, these agreements could have major effects on patients' and the public's health.  Since these concerns have been essentially ignored by the US medical and health care literature, (although they have appeared in UK journals, Australian, and New Zealand journals in English), they I will discuss them below. Worthy of further discussion is the possibility that these potential threats to health care and public health may arise not just from ideological disagreements, but also from health care corporations' increasing capture of government, facilitated by the conflicts of interest generated by the revolving door. Read More »